Chemoinformaics analysis of Furo[2,3-h]quinoline
Molecular Weight | 169.183 | nRot | 0 |
Heavy Atom Molecular Weight | 162.127 | nRig | 18 |
Exact Molecular Weight | 169.053 | nRing | 3 |
Solubility: LogS | -3.335 | nHRing | 2 |
Solubility: LogP | 2.374 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
nHA | 2 | APOL | 24.9396 |
nHD | 0 | BPOL | 9.89845 |
QED | 0.547 |
Synth | 2.352 |
Natural Product Likeliness | 0.673 |
NR-PPAR-gamma | 0.088 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.007 |
Pgp-sub | 0.002 |
HIA | 0.01 |
CACO-2 | -5.011 |
MDCK | 0.0000175 |
BBB | 0.039 |
PPB | 0.990014 |
VDSS | 0.501 |
FU | 0.0126696 |
CYP1A2-inh | 0.945 |
CYP1A2-sub | 0.09 |
CYP2c19-inh | 0.276 |
CYP2c19-sub | 0.052 |
CYP2c9-inh | 0.612 |
CYP2c9-sub | 0.639 |
CYP2d6-inh | 0.446 |
CYP2d6-sub | 0.362 |
CYP3a4-inh | 0.712 |
CYP3a4-sub | 0.179 |
CL | 11.1 |
T12 | 0.907 |
hERG | 0.021 |
Ames | 0.804 |
ROA | 0.88 |
SkinSen | 0.919 |
Carcinogencity | 0.782 |
EI | 0.95 |
Respiratory | 0.143 |
NR-Aromatase | 0.792 |
Antiviral | No |
Prediction | 0.595563 |